Clinical trial
Safety and Efficacy Study of Glufosfamide in Ovarian Cancer
NCT00442598 · Eleison Pharmaceuticals LLC., Industry · Terminated
Key facts
| NCT number | NCT00442598 |
|---|---|
| Title | Safety and Efficacy Study of Glufosfamide in Ovarian Cancer |
| Official title | An Open-Label Phase 2 Study of the Safety and Efficacy of Glufosfamide in Ovarian Cancer |
| Lead sponsor | Eleison Pharmaceuticals LLC., Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Ovarian Cancer |
| Intervention type | Drug |
| Interventions | Glufosfamide |
| Enrollment | 17 |
| Start date | Jan 1, 2007 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Mar 2, 2007 |
| Last update posted | Mar 10, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: